These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25644328)

  • 1. Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence.
    Braamskamp MJ; Kusters DM; Avis HJ; Smets EM; Wijburg FA; Kastelein JJ; Wiegman A; Hutten BA
    Paediatr Drugs; 2015 Apr; 17(2):159-66. PubMed ID: 25644328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency and problems of statin therapy in patients with heterozygous familial hypercholesterolemia.
    Korneva V; Kuznetsova T; Julius U
    Atheroscler Suppl; 2019 Dec; 40():79-87. PubMed ID: 31818452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhood.
    Braamskamp MJ; Kusters DM; Wiegman A; Avis HJ; Wijburg FA; Kastelein JJ; van Trotsenburg AS; Hutten BA
    Atherosclerosis; 2015 Aug; 241(2):427-32. PubMed ID: 26079405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid Lowering Therapy with Statins in Patients with Heterozygous Familial Hypercholesterolemia].
    Korneva VA; Kuznetsova TY; Tihova GP
    Kardiologiia; 2019 Apr; 59(3):27-35. PubMed ID: 30990138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.
    Huijgen R; Abbink EJ; Bruckert E; Stalenhoef AF; Imholz BP; Durrington PN; Trip MD; Eriksson M; Visseren FL; Schaefer JR; Kastelein JJ;
    Clin Ther; 2010 Apr; 32(4):615-25. PubMed ID: 20435231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal treatment patterns among US patients with atherosclerotic cardiovascular disease or familial hypercholesterolemia initiating lipid-lowering pharmacotherapy.
    Burke JP; Simpson RJ; Paoli CJ; McPheeters JT; Gandra SR
    J Clin Lipidol; 2016; 10(6):1470-1480.e3. PubMed ID: 27919365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia.
    Khine H; Yuet WC; Adams-Huet B; Ahmad Z
    Am Heart J; 2016 Sep; 179():1-9. PubMed ID: 27595674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: efficacy and tolerability.
    Carreau V; Girardet JP; Bruckert E
    Paediatr Drugs; 2011 Aug; 13(4):267-75. PubMed ID: 21692550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
    Davidson M
    Clin Ther; 2013 Aug; 35(8):1247-52. PubMed ID: 23916045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting non-adherence in patients with familial hypercholesterolemia.
    Galema-Boers JM; Lenzen MJ; van Domburg RT; Roeters van Lennep J; van Bruchem-van de Scheur GG; Sijbrands EJ; Langendonk JG
    Eur J Clin Pharmacol; 2014 Apr; 70(4):391-7. PubMed ID: 24449092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of young adults with familial hypercholesterolemia after participation in clinical trials during childhood.
    Langslet G; Bogsrud MP; Halvorsen I; Fjeldstad H; Retterstøl K; Veierød MB; Ose L
    J Clin Lipidol; 2015; 9(6):778-785. PubMed ID: 26687698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatment and adherence of subjects <40 years with diagnosis of heterozygous familial hypercholesterolemia.
    Casula M; Scotti L; Tragni E; Merlino L; Corrao G; Catapano AL
    Atherosclerosis; 2016 Nov; 254():172-178. PubMed ID: 27750108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study.
    Bos S; Duvekot MH; Ten Kate GR; Verhoeven AJ; Mulder MT; Schinkel AF; Nieman K; Watts GF; Sijbrands EJ; Roeters van Lennep JE
    Atherosclerosis; 2017 Jan; 256():62-66. PubMed ID: 28012444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early initiation of statin treatment in children with familial hypercholesterolaemia.
    Braamskamp MJ; Hutten BA; Wiegman A
    Curr Opin Lipidol; 2015 Jun; 26(3):236-9. PubMed ID: 25943840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia.
    Avis HJ; Vissers MN; Stein EA; Wijburg FA; Trip MD; Kastelein JJ; Hutten BA
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1803-10. PubMed ID: 17569881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin treatment in children with familial hypercholesterolemia: the younger, the better.
    Rodenburg J; Vissers MN; Wiegman A; van Trotsenburg AS; van der Graaf A; de Groot E; Wijburg FA; Kastelein JJ; Hutten BA
    Circulation; 2007 Aug; 116(6):664-8. PubMed ID: 17664376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education.
    Wei MY; Ito MK; Cohen JD; Brinton EA; Jacobson TA
    J Clin Lipidol; 2013; 7(5):472-83. PubMed ID: 24079289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hypercholesterolemia in a large ambulatory population: Statin use, optimal treatment, and identification for advanced medical therapies.
    Knickelbine T; Lui M; Garberich R; Miedema MD; Strauss C; VanWormer JJ
    J Clin Lipidol; 2016; 10(5):1182-7. PubMed ID: 27678435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale.
    Teramoto T; Kondo A; Kiyosue A; Harada-Shiba M; Ishigaki Y; Tobita K; Kawabata Y; Ozaki A; Baccara-Dinet MT; Sata M
    Lipids Health Dis; 2017 Jun; 16(1):121. PubMed ID: 28623954
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.